Comparative biodistribution analysis of umbilical cord mesenchymal stromal cells via different administration routes in rabbit models

Xiao, Liang; Liu, Chunlin; Wang, Yuqian; Xiao, Fucheng; Cai, Jiahua; Qu, Shoukang; Xu, Xiaojuan; Wang, Xiaoliang; Liu, Yue; Peng, Yutao; Liu, Jia

doi:10.2478/acph-2026-0004

Abstract

Umbilical cord mesenchymal stem cells (UC-MSCs) have shown therapeutic potential in renal diseases due to their homing ability. This study compared the effects of three administration routes (intravenous, local renal injection, and interventional injection) on UC-MSC distribution in kidney tissue. Eighteen New Zealand rabbits were assigned to the three groups (n = 6 each), and DiI-labelled UC-MSCs were tracked using confocal microscopy to evaluate their distribution in the kidney, lung, and brain. Local renal injection led to high MSC concentrations at the injection site, but distribution to the contralateral kidney was minimal and comparable to that of intravenous injection. Intravenous delivery via the marginal ear vein was simple and convenient but resulted in limited renal homing (< 1 %) and no significant difference between kidneys. Interventional injection achieved the highest delivery efficiency (12.4 %) and a more uniform renal distribution. Notably, inflammatory cytokine levels (IL-6, TNF-α, IL-10) were significantly elevated in the local injection group (p < 0.05). These results indicated that the choice of administration route critically affects MSC targeting and therapeutic potential, and interventional injection may offer the most effective strategy for precise UC-MSC delivery in renal therapy.

References

M. F. Pittenger, D. E. Discher, B. M. Péault, D. G. Phinney, J. M. Hare and A. I. Caplan, Mesenchymal stem cell perspective: Cell biology to clinical progress, npj Regen. Med. 4(1) (2019) Article ID 22 (15 pages); https://doi.org/10.1038/s41536-019-0083-6
Search in Google Scholar Back to article
P. Wanyan, X. Wang, N. Li, Y. Huang, Y. She and L. Zhang, Mesenchymal stem cells therapy for acute kidney injury: A systematic review with meta-analysis based on rat model, Front. Pharmacol. 14 (2023) Article ID 1099056 (14 pages); https://doi.org/10.3389/fphar.2023.1099056
Search in Google Scholar Back to article
X. Han, J. Wang, R. Li, M. Huang, G. Yue, L. Guan, Y. Deng, W. Cai and J. Xu, Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1alpha-TFAM pathway, Int. J. Molecular Sci. 24(5) (2023) Article ID 22 (19 pages); https://doi.org/10.3390/ijms24054696
Search in Google Scholar Back to article
S. Afra and M. M. Matin, Potential of mesenchymal stem cells for bioengineered blood vessels in comparison with other eligible cell sources, Cell Tissue Res. 380 (2020) 1–13; https://doi.org/10.1007/s00441-019-03161-0
Search in Google Scholar Back to article
Z. W. Htay, C. F. S. Ng, Y. Kim, Y.-H. Lim, M. Iwagami and M. Hashizume, Associations between short-term exposure to ambient temperature and renal disease mortality in Japan during 1979–2019: A time-stratified case-crossover analysis, Environmental Epidemiol. 8(1) (2024) e293 (7 pages); https://doi.org/10.1097/ee9.0000000000000293
Search in Google Scholar Back to article
K. Iseri, M. Iyoda, H. Ohtaki, K. Matsumoto, Y. Wada, T. Suzuki, Y. Yamamoto, T. Saito, K. Hihara, S. Tachibana, K. Honda and T. Shibata, Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats, Am. J. Physiol. Renal Physiol. 310(11) (2016) F1182-91; https://doi.org/10.1152/ajprenal.00165.2016
Search in Google Scholar Back to article
R. J. Cheng, A. J. Xiong, Y. H. Li, S. Y. Pan, Q. P. Zhang, Y. Zhao, Y. Liu and T. N. Marion, Mesenchymal stem cells: Allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients, Front. Cell Dev. Biol. 7 (2019) Article ID 285 (13 pages); https://doi.org/10.3389/fcell.2019.00285
Search in Google Scholar Back to article
J. Barbado, S. Tabera, A. Sánchez and J. García-Sancho, Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis, Lupus 27(13) (2018) 2161–2165; https://doi.org/10.1177/0961203318804922
Search in Google Scholar Back to article
H. S. Kim, J. S. Lee, H. K. Lee, E. J. Park, H. W. Jeon, Y. J. Kang, T. Y. Lee, K. S. Kim, S. C. Bae, J. H. Park and S. B. Han, Mesenchymal stem cells ameliorate renal inflammation in adriamycin-induced nephropathy, Immune Netw. 19(5) (2019) e36 (10 pages); https://doi.org/10.4110/in.2019.19.e36
Search in Google Scholar Back to article
N. Starc, M. Li, M. Algeri, A. Conforti, L. Tomao, A. Pitisci, F. Emma, G. Montini, P. Messa, F. Locatelli, M. E. Bernardo and M. Vivarelli, Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome, Cytotherapy 20(3) (2018) 322–334; https://doi.org/10.1016/j.jcyt.2017.12.001
Search in Google Scholar Back to article
H. H. Chang, S. P. Hsu and C. T. Chien, Intrarenal transplantation of hypoxic preconditioned mesenchymal stem cells improves glomerulonephritis through anti-oxidation, anti-ER stress, anti-inflammation, anti-apoptosis, and anti-autophagy, Antioxidants (Basel) 9(1) (2019); Article ID 2 (17 pages) https://doi.org/10.3390/antiox9010002
Search in Google Scholar Back to article
V. A. Varela, E. B. Oliveira-Sales, E. Maquigussa, F. T. Borges, P. P. Gattai, A. D. S. Novaes, C. G. Shimoura, R. R. Campos and M. A. Boim, Treatment with mesenchymal stem cells improves reno-vascular hypertension and preserves the ability of the contralateral kidney to excrete sodium, Kidney Blood Pressure Res. 44(6) (2019) 1404–1415; https://doi.org/10.1159/000503346
Search in Google Scholar Back to article
M. Gregorini, R. Maccario, M.A. Avanzini, V. Corradetti, A. Moretta, C. Libetta, P. Esposito, F. Bosio, A. Dal Canton and T. Rampino, Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms, Mayo Clinic Proc. 88(10) (2013) 1174–1179; https://doi.org/10.1016/j.mayocp.2013.06.021
Search in Google Scholar Back to article
Y. Shi, J. Xie, M. Yang, J. Ma and H. Ren, Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation, Ann. Transl. Med. 7(16) (2019) Article ID 3 (9 pages); https://doi.org/10.21037/atm.2019.07.71
Search in Google Scholar Back to article
F. Yu, J. Chen, X. Wang, Q. Cai, K. Chen and Y. He, MSC-Derived exosomes prevent peritoneal fibroblast transdifferentiation in peritoneal dialysis-associated peritoneal fibrosis, Nephrol. Dialysis Transplant. 38(Supplement_1) (2023) Article ID 4662 (1 page); https://doi.org/10.1093/ndt/gfad063c_4662
Search in Google Scholar Back to article
E. Maličev and K. Jazbec, An overview of mesenchymal stem cell heterogeneity and concentration, Pharmaceuticals 17(3) (2024) Article ID 350 (14 pages); https://doi.org/10.3390/ph17030350
Search in Google Scholar Back to article
S. Joshi, S. Allabun, S. Ojo, M. S. Alqahtani, P. K. Shukla, M. Abbas, C. Wechtaisong and H. M. Almohiy, Enhanced drug delivery system using mesenchymal stem cells and membrane-coated nanoparticles, Molecules 28(5) (2023) Article ID 2130 (25 pages); https://doi.org/10.3390/molecules28052130
Search in Google Scholar Back to article
C. Qi, H. Shi, M. Fan, W. Chen, H. Yao, C. Jiang, L. Meng, S. Pang and R. Lin, Microvesicles from bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by transferring thrombospondin-2, Cell Commun. Signal. 21(1) (2023) Article ID 274 (15 pages); https://doi.org/10.1186/s12964-023-01127-y
Search in Google Scholar Back to article
A. F. Wise, T. M. Williams, M. B. Kiewiet, N. L. Payne, C. Siatskas, C. S. Samuel and S. D. Ricardo, Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury, Am. J. Physiol. Renal Physiol. 306(10) (2014) F1222-35; https://doi.org/10.1152/ajprenal.00675.2013
Search in Google Scholar Back to article
S. Qi and D. Wu, Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis, Int. J. Mol. Med. 32(6) (2013) 1262–1272; https://doi.org/10.3892/ijmm.2013.1517
Search in Google Scholar Back to article
M. Han, Z. Zhang, Z. Liu, Y. Liu, H. Zhao, B. Wang, C. Zhang, H. Shang, Y. Li and S. Wang, Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair, Biomaterials Advan. 149 (2023) Article ID 213396; https://doi.org/10.1016/j.bioadv.2023.213396
Search in Google Scholar Back to article
C. K. Ward, R. G. Gill, R. S. Liddell and J. E. Davies, Umbilical cord stem cell lysate: a new biologic injectate for the putative treatment of acute temporomandibular joint inflammation, J. Inflamm. Res. 16 (2023) 4287–4300; https://doi.org/10.2147/R.S420741
Search in Google Scholar Back to article
S. J. Lee, M. O. Ryu, M. S. Seo, S. B. Park, J. O. Ahn, S. M. Han, K. S. Kang, D. H. Bhang and H. Y. Youn, Mesenchymal stem cells contribute to improvement of renal function in a canine kidney injury model, In vivo 31(6) (2017) 1115–1124; https://doi.org/10.21873/invivo.11177
Search in Google Scholar Back to article
J. M. Quimby, T. L. Webb, D. S. Gibbons and S. W. Dow, Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: A pilot study, J. Feline Med. Surgery 13(6) (2011) 418–426; https://doi.org/10.1016/j.jfms.2011.01.005
Search in Google Scholar Back to article
M. Taninokuchi Tomassoni, Y. Zhou, L. Braccischi, F. Modestino, J. Fukuda and C. Mosconi, Trans-arterial stem cell injection (TASI): The role of interventional radiology in regenerative medi cine, J. Clin. Med. 13(3) (2024) Article ID 910 (13 pages); https://doi.org/10.3390/jcm13030910
Search in Google Scholar Back to article
S. Levitte, A. Ganguly, S. Frolik, A. A. Guevara-Tique, S. Patel, A. Tadas, O. Klein, D. Shyr, R. Agarwal-Hashmi and L. Beach, Precision delivery of steroids as a rescue therapy for gastrointestinal graft-versus-host disease in pediatric stem cell transplant recipients, J. Clin. Med. 12(13) (2023) Article ID 4229 (6 pages); https://doi.org/10.3390/jcm12134229
Search in Google Scholar Back to article
E. Cambria, J. Steiger, J. Günter, A. Bopp, P. Wolint, S. P. Hoerstrup and M. Y. Emmert, Cardiac regenerative medicine: The potential of a new generation of stem cells, Transfusion Med. Hemo-therapy 43(4) (2016) 275–281; https://doi.org/10.1159/000448179
Search in Google Scholar Back to article
Y.-H. Chen, T. Xiao, X.-M. Zheng, Y. Xu, K.-T. Zhuang, W.-J. Wang, X.-M. Chen, Q. Hong and G.-Y. Cai, Local renal treatments for acute kidney injury: A review of current progress and future translational opportunities, J. Endourology 38(5) (2024) 466–479; https://doi.org/10.1089/end.2023.0705
Search in Google Scholar Back to article
R. Binato, T. de Souza Fernandez, C. Lazzarotto-Silva, B. Du Rocher, A. Mencalha, L. Pizzatti, L. F. Bouzas and E. Abdelhay, Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy, Cell Prolif. 46(1) (2013) 10–22; https://doi.org/10.1111/cpr.12002
Search in Google Scholar Back to article
G. Cai, Y. Lu, J. Chen, D. Yang, R. Yan, M. Ren, S. He, S. Wu and Y. Zhao, Brain-wide mapping of c-Fos expression with fluorescence micro-optical sectioning tomography in a chronic sleep deprivation mouse model, Neurobiol. Stress 20 (2022) Article ID 100478 (13 pages); https://doi.org/10.1016/j.ynstr.2022.100478
Search in Google Scholar Back to article
A. Mii, A. Shimizu, H. Yamaguchi and S. Tsuruoka, Renal complications after hematopoietic stem cell transplantation: Role of graft-versus-host disease in renal thrombotic microangiopathy, J. Nippon Med. School 87(1) (2020) 7–12; https://doi.org/10.1272/jnms.JNMS.2020_87-102
Search in Google Scholar Back to article
H. Zhou, Z. Liu, Y. Wang, X. Wen, E. H. Amador, L. Yuan, X. Ran, L. Xiong, Y. Ran, W. Chen and Y. Wen, Colorectal liver metastasis: molecular mechanism and interventional therapy, Sig. Trans-duct. Target. Ther. 7(1) (2022) Article ID 70 (25 pages); https://doi.org/10.1038/s41392-022-00922-2
Search in Google Scholar Back to article
D. Luger, M. J. Lipinski, P. C. Westman, D. K. Glover, J. Dimastromatteo, J. C. Frias, M. T. Albelda, S. Sikora, A. Kharazi and G. Vertelov, Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy, Circulation Res. 120(10) (2017) 1598–1613; https://doi.org/10.1161/CIRCRESAHA.117.310599
Search in Google Scholar Back to article
Y. Wang and Y. Guo, RenalGuard system and conventional hydration for preventing contrast- associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis, Int. J. Cardiology 333 (2021) 83–89; https://doi.org/10.1016/j.ij-card.2021.02.071
Search in Google Scholar Back to article
R. H. Lee, A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine and D. J. Prockop, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell 5(1) (2009) 54–63; https://doi.org/10.1016/j.stem.2009.05.003
Search in Google Scholar Back to article
S. Zonta, M. De Martino, G. Bedino, G. Piotti, T. Rampino, M. Gregorini, F. Frassoni, A. Dal Canton, P. Dionigi and M. Alessiani, Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: Endovenous or arterial?, Transplant. Proc. 42(4) (2010) 1336–1340; https://doi.org/10.1016/j.transproceed.2010.03.081
Search in Google Scholar Back to article
T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis and R. L. Wilensky, A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction, Eur. Heart J. 27(9) (2006) 1114–1122; https://doi.org/10.1093/eurheartj/ehi818
Search in Google Scholar Back to article
D. Lu, Y. Li, L. Wang, J. Chen, A. Mahmood and M. Chopp, Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury, J. Neurotrauma 18(8) (2001) 813–819; https://doi.org/10.1089/089771501316919175
Search in Google Scholar Back to article
P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C. van Zijl, J. Huang and J. W. Bulte, Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia, Stroke 39(5) (2008) 1569–1574; https://doi.org/10.1161/strokeaha.107.502047
Search in Google Scholar Back to article
G. F. Muschler, C. Nakamoto and L. G. Griffith, Engineering principles of clinical cell-based tissue engineering, J. Bone Joint Surgery 86(7) (2004) 1541–1558; https://doi.org/10.2106/00004623-200407000-00029
Search in Google Scholar Back to article
Y. K. Chang, M. H. Chen, Y. H. Chiang, Y. F. Chen, W. H. Ma, C. Y. Tseng, B. W. Soong, J. H. Ho and O. K. Lee, Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells, J. Biomed. Sci. 18 (2011) Article ID 54 (9 pages); https://doi.org/10.1186/1423-0127-18-54
Search in Google Scholar Back to article
I. M. Barbash, P. Chouraqui, J. Baron, M. S. Feinberg, S. Etzion, A. Tessone, L. Miller, E. Guetta, D. Zipori, L. H. Kedes, R. A. Kloner and J. Leor, Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution, Circulation 108(7) (2003) 863–868; https://doi.org/10.1161/01.Cir.0000084828.50310.6a
Search in Google Scholar Back to article
S. M. Devine, A. M. Bartholomew, N. Mahmud, M. Nelson, S. Patil, W. Hardy, C. Sturgeon, T. Hewett, T. Chung, W. Stock, D. Sher, S. Weissman, K. Ferrer, J. Mosca, R. Deans, A. Moseley and R. Hoffman, Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion, Exp. Hematology 29(2) (2001) 244–255; https://doi.org/10.1016/s0301-472x(00)00635-4
Search in Google Scholar Back to article
J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg and A. I. Caplan, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, Cells Tissues Organs 169(1) (2001) 12–20; https://doi.org/10.1159/000047856
Search in Google Scholar Back to article
S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew and R. Hoffman, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood 101(8) (2003) 2999–3001; https://doi.org/10.1182/blood-2002-06-1830
Search in Google Scholar Back to article
J. W. Lee, X. Fang, N. Gupta, V. Serikov and M. A. Matthay, Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung, PNAS 106(38) (2009) 16357–16362; https://doi.org/10.1073/pnas.0907996106
Search in Google Scholar Back to article
G. Moll, R. Jitschin, L. von Bahr, I. Rasmusson-Duprez, B. Sundberg, L. Lönnies, G. Elgue, K. Nilsson-Ekdahl, D. Mougiakakos, J. D. Lambris, O. Ringdén, K. Le Blanc and B. Nilsson, Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses, PloS one 6(7) (2011) e21703 (9 pages); https://doi.org/10.1371/journal.pone.0021703
Search in Google Scholar Back to article
I. U. Schraufstatter, R. G. Discipio, M. Zhao and S. K. Khaldoyanidi, C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation, J. Immunol. 182(6) (2009) 3827–3836; https://doi.org/10.4049/jimmunol.0803055
Search in Google Scholar Back to article
A. I. Caplan and D. Correa, The MSC: an injury drugstore, Cell Stem Cell 9(1) (2011) 11–15; https://doi.org/10.1016/j.stem.2011.06.008
Search in Google Scholar Back to article
A. Shabbir, D. Zisa, H. Lin, M. Mastri, G. Roloff, G. Suzuki and T. Lee, Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cell-mediated cardiac repair, Am. J. Physiol. Heart Circul. Physiol. 299(5) (2010) H1428–1438; https://doi.org/10.1152/ajpheart.00488.2010
Search in Google Scholar Back to article

Comparative biodistribution analysis of umbilical cord mesenchymal stromal cells via different administration routes in rabbit models

Abstract

Paradigm

My account